Nature CommunicationsNeurosciencePeer-reviewed journal article
Abnormal AMPAR-mediated synaptic plasticity, cognitive and autistic-like behaviors in a missense Fmr1 mutant mouse model of Fragile X syndrome
Marta Prieto, Alessandra FolciiD, Gwénola PouponiD, Sara SchiaviiD, Valeria BuzzelliiD, Marie PronotiD, Urielle FrançoisiD, Paula A. PousinhaiD, Norma Lattuada, Sophie AbélanetiD, Sara Castagnola, Magda Chafaï, Anouar KhayachiiD, Carole GwizdekiD, Frédéric BrauiD, Emmanuel DevaliD, Maura FrancoliniiD, Barbara BardoniiD, Yann HumeauiD, Viviana TrezzaiD, Stéphane MartiniD
Abstract
Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability and the best-described monogenic cause of autism. FXS is usually caused by a CGG-repeat expansion in the FMR1 gene leading to its silencing and the loss-of-expression of the Fragile X Mental Retardation Protein (FMRP). Missense mutations were also identified in FXS patients, including the recurrent FMRP-R138Q mutation. To investigate the mechanisms underlying FXS in these patients, we generated a knock-in mouse model (Fmr1R138Q) expressing the FMRP-R138Q protein. We demonstrate that the Fmr1R138Q hippocampus has an increased spine density associated with postsynaptic ultrastructural defects and increased AMPA receptor surface expression. Combining biochemical assays, high-resolution imaging and electrophysiological recordings, we also show that the mutation impairs the hippocampal long-term potentiation (LTP) and leads to socio-cognitive deficits in Fmr1R138Q mice. These findings reveal that the R138Q mutation impacts the synaptic functions of FMRP and highlight potential mechanisms causing FXS in FMRP-R138Q patients.
- Citations
- 41
- FWCI
- 4.52
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Astroglial FMRP modulates synaptic signaling and behavior phenotypes in FXS mouse model
Shan‐Xue Jin, Haruki Higashimori, … Yongjie Yang·GliaPeer-reviewed·Sep 24, 2020
- A serotonergic mechanism is involved in the pro-cognitive effect of AM6545 treatment in a mouse model of fragile X syndrome
Lucía de los Reyes‐Ramírez, Araceli Bergadà‐Martínez, … Andrés Ozaita·Translational PsychiatryPeer-reviewed·Aug 20, 2026
- Hippocampal gamma-band oscillopathy in a mouse model of Fragile X Syndrome
Evangelia Pollali, Jan‐Oliver Hollnagel, Gürsel Çalışkan·bioRxiv·Apr 24, 2021
- Cell-Specific Disruptions in the Basolateral Amygdala-Accumbens Pathway of Fragile X Mice
Gabriele Giua, Olivier Lassalle, … Olivier J. Manzoni·bioRxiv·Aug 1, 2023
- Impaired reliability and precision of spiking in adults but not juveniles in a mouse model of Fragile X Syndrome
Deepanjali Dwivedi, Sumantra Chattarji, Upinder S. Bhalla·eNeuroPeer-reviewed·Nov 1, 2019
- Carbamazepine restores neuronal signaling, protein synthesis and cognitive function in a mouse model of fragile X syndrome
Qi Ding, Fan Zhang, … Hongbing Wang·International Journal of Molecular SciencesPeer-reviewed·Dec 7, 2020